Literature DB >> 16873696

Paradoxical stimulation of glucagon secretion by high glucose concentrations.

Albert Salehi1, Elaine Vieira, Erik Gylfe.   

Abstract

Hypersecretion of glucagon contributes to the dysregulation of glucose homeostasis in diabetes. To clarify the underlying mechanism, glucose-regulated glucagon secretion was studied in mouse pancreatic islets and clonal hamster In-R1-G9 glucagon-releasing cells. Apart from the well-known inhibition of secretion with maximal effect around 7 mmol/l glucose, we discovered that mouse islets showed paradoxical stimulation of glucagon release at 25-30 mmol/l and In-R1-G9 cells at 12-20 mmol/l sugar. Whereas glucagon secretion in the absence of glucose was inhibited by hyperpolarization with diazoxide, this agent tended to further enhance secretion stimulated by high concentrations of the sugar. Because U-shaped dose-response relationships for glucose-regulated glucagon secretion were observed in normal islets and in clonal glucagon-releasing cells, both the inhibitory and stimulatory components probably reflect direct effects on the alpha-cells. Studies of isolated mouse alpha-cells indicated that glucose inhibited glucagon secretion by lowering the cytoplasmic Ca(2+) concentration. However, stimulation of glucagon release by high glucose concentrations did not require elevation of Ca(2+), indicating involvement of novel mechanisms in glucose regulation of glucagon secretion. A U-shaped dose-response relationship for glucose-regulated glucagon secretion may explain why diabetic patients with pronounced hyperglycemia display paradoxical hyperglucagonemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873696     DOI: 10.2337/db06-0080

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  71 in total

1.  Paracrine regulation of glucagon secretion: the β/α/δ model.

Authors:  Margaret Watts; Joon Ha; Ofer Kimchi; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-02       Impact factor: 4.310

Review 2.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

3.  γ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes.

Authors:  J Taneera; Z Jin; Y Jin; S J Muhammed; E Zhang; S Lang; A Salehi; O Korsgren; E Renström; L Groop; B Birnir
Journal:  Diabetologia       Date:  2012-04-27       Impact factor: 10.122

4.  Modeling the pancreatic α-cell: dual mechanisms of glucose suppression of glucagon secretion.

Authors:  Margaret Watts; Arthur Sherman
Journal:  Biophys J       Date:  2014-02-04       Impact factor: 4.033

Review 5.  Regulation of Carbohydrate Energy Metabolism in Drosophila melanogaster.

Authors:  Jaakko Mattila; Ville Hietakangas
Journal:  Genetics       Date:  2017-12       Impact factor: 4.562

6.  Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells.

Authors:  Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Anne Clark; Jonathan N Walker; Paul R Johnson; Patrik Rorsman
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

7.  Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.

Authors:  Reshma Ramracheya; Caroline Ward; Makoto Shigeto; Jonathan N Walker; Stefan Amisten; Quan Zhang; Paul R Johnson; Patrik Rorsman; Matthias Braun
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

8.  Insulin signaling in alpha cells modulates glucagon secretion in vivo.

Authors:  Dan Kawamori; Amarnath J Kurpad; Jiang Hu; Chong Wee Liew; Judy L Shih; Eric L Ford; Pedro L Herrera; Kenneth S Polonsky; Owen P McGuinness; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

9.  Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure.

Authors:  M González; U Böer; C Dickel; T Quentin; I Cierny; E Oetjen; W Knepel
Journal:  Diabetologia       Date:  2008-09-02       Impact factor: 10.122

10.  Inhibitory effects of leptin on pancreatic alpha-cell function.

Authors:  Eva Tudurí; Laura Marroquí; Sergi Soriano; Ana B Ropero; Thiago M Batista; Sandra Piquer; Miguel A López-Boado; Everardo M Carneiro; Ramón Gomis; Angel Nadal; Ivan Quesada
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.